Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Viatris Swats Away Concerns Over Divestment Valuations
As US-Based Firm Updates On Glatiramer And Botox Biosimilar
Aug 12 2022
•
By
Dean Rudge
Rising rates are no concern to Viatris currently • Source: Shutterstock
(Alamy Stock Photo)
More from Strategy
More from Business
